awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35008618-45802F90-27F5-4DFC-8604-2EABD5272163
Q35008618-45802F90-27F5-4DFC-8604-2EABD5272163
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35008618-45802F90-27F5-4DFC-8604-2EABD5272163
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.
P2860
Q35008618-45802F90-27F5-4DFC-8604-2EABD5272163
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35008618-45802F90-27F5-4DFC-8604-2EABD5272163
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c95fad5ac500ecaa2554dfdacc6589c0d0b8fdf
P2860
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.